Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mary Flack
Psoriatic Skin Molecular and Histopathological Profiles Following Treatment With Risankizumab Versus Ustekinumab
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Efficacy and Safety of Continuous Risankizumab Therapy vs Treatment Withdrawal in Patients With Moderate to Severe Plaque Psoriasis
JAMA Dermatology
Dermatology
Medicine
Related publications
Risankizumab Versus Ustekinumab for Plaque Psoriasis: A Critical Appraisal
British Journal of Dermatology
Dermatology
Medicine
Risankizumab vs. Ustekinumab for Plaque Psoriasis
British Journal of Dermatology
Dermatology
Medicine
Pms38 - Cost Effectiveness Analysis of Secukinumab Versus Ustekinumab for the Treatment of Psoriatic Arthritis in the United States
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Efficacy and Safety of Ustekinumab in Patients With Psoriasis and Psoriatic Arthritis
Clinical pharmacology and therapy
Metabolic Parameters in Psoriatic Patients Treated With Interleukin-12/23 Blockade (Ustekinumab)
Journal of Dermatology
Dermatology
Medicine
Pms45 - Cost Per Responder Analysis Following a 48-Week Psoriatic Arthritis Treatment With Secukinumab Versus Adalimumab From the Portuguese Payer Perspective
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Retraction Statement: Metabolic Parameters in Psoriatic Patients Treated With Interleukin-12/23 Blockade (Ustekinumab)
Journal of Dermatology
Dermatology
Medicine
Comparison of Normal Versus Imiquimod-Induced Psoriatic Skin in Mice for Penetration of Drugs and Nanoparticles
International Journal of Nanomedicine
Organic Chemistry
Biophysics
Biomaterials
Pharmaceutical Science
Medicine
Bioengineering
Drug Discovery
Nanoscience
Nanotechnology
Risankizumab for the Treatment of Plaque Psoriasis in Adults
Prescriber
Pharmacology
